Adel Chergui

437 citations
16 papers · 385 · h-index 9

Impact in

  • Toxicology top 5%
    • Bioactive Compounds and Antitumor Agents
    • Synthesis and Biological Evaluation
    • Synthesis and biological activity

Papers in

    • Cancer therapeutics and mechanisms 7
    • Colorectal Cancer Treatments and Studies 3
    • PARP inhibition in cancer therapy 2

Adel Chergui

16 papers receiving 375 citations

Peers

Adel Chergui
Comparison fields: 5 of 52
  • Toxicology 71
  • Organic Chemistry 155
  • Molecular Biology 283
  • Oncology 97
  • Pharmacology 51
Replace Mark D. Prairie with:
Mark D. Prairie United States
Monica Abdelmalak United States
Nikhil Reddy Madadi United States
Ilse Gebhard United States
Nancy A. Wicnienski United States
Maria M. Bontemps‐Gracz Italy
Irina Chuckowree United Kingdom
Lars H. Jensen Denmark
J.A. Hartley United Kingdom
Muthukaman Nagarajan United States
Adel Chergui relative to Mark D. Prairie United States Mark D. Prairie's profile →
Citations per field
00.5×10×15×20×23×
Mark D. Prairie · 1×
Citations per year

Countries citing papers authored by Adel Chergui

Since Specialization
Citations

This map shows the geographic impact of Adel Chergui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adel Chergui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adel Chergui more than expected).

Fields of papers citing papers by Adel Chergui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adel Chergui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adel Chergui. The network helps show where Adel Chergui may publish in the future.

Co-authors

The 25 scholars most cited alongside Adel Chergui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Adel Chergui Line = papers co-authored together Adel Chergui links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1 201281
2 201267
3 201459
4 201255
5 201448
6 201420
7 201719
8 201417
9 20238
10
[Non invasive measurement of the cerebral blood flow in infants with hydrocephalus].
19854
11 20192
12
[Ultrasonic diagnosis and follow-up of aneurysms of the ampulla of Galen in infants].
19871
13 20211
14
[Echographic monitoring of post-hemorrhagic ventricular dilatations in premature newborn infants. Value of the determination of a ventricular index].
19851
15 20201
16 20221

About Adel Chergui

Adel Chergui is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Neurology and Pulmonary and Respiratory Medicine, having authored 16 papers that have together received 385 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (7 papers), Colorectal Cancer Treatments and Studies (3 papers), Synthesis and biological activity (3 papers), Bioactive Compounds and Antitumor Agents (3 papers), Traumatic Brain Injury and Neurovascular Disturbances (3 papers), Synthesis and Biological Activity (2 papers), Neonatal and fetal brain pathology (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Toxicology (71 citations), Organic Chemistry (155 citations), Molecular Biology (283 citations), Oncology (97 citations) and Pharmacology (51 citations). Adel Chergui has collaborated with scholars based in United States and Japan. Frequent co-authors include Yves Pommier, Christophe Marchand, Keli Agama, Mark Cushman, Andrew G. Stephen, Andrew Morrell, Martin Conda‐Sheridan, Amèlie Renaud, Barry R. O’Keefe and Junko Murai. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Clinical Oncology, Molecular Cancer Therapeutics, SLAS DISCOVERY and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact